NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor

Rhea-AI Summary

NovaBay Pharmaceuticals (NYSE American: NBY) has announced a conference call and webcast scheduled for September 29, 2021, at 4:30 p.m. ET to discuss its acquisition of DERMAdoctor. The event will include a slide presentation and is open for pre-registration. Participants can dial in from the U.S. or internationally to gain access. NovaBay focuses on anti-infective consumer products, while DERMAdoctor is recognized for its clinical skincare solutions. The call will also be archived for later accessibility until October 14, 2021.

Positive

• Acquisition of DERMAdoctor enhances product portfolio and market presence.
• Pre-registration for the conference call streamlines participant access.

Negative

• None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay^® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call and webcast with accompanying slide presentation today, Wednesday, September 29, 2021 beginning at 4:30 p.m. Eastern time.

Date/Time:	Wednesday, September 29, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration:	Participants can pre-register for the conference call here:
	Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In:	Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:
	866-777-2509 from within the U.S.
	412-317-5413 from outside the U.S.

The live webcast of the conference call with accompanying slide presentation also will be available at http://novabay.com/investors/events. The slide deck will also be posted here for those joining by phone. A replay of the call will be available beginning two hours after its completion through October 14, 2021 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 10159955.

The webcast and accompany slide presentation will also be archived at http://novabay.com/investors/events.

About NovaBay Pharmaceuticals:

NovaBay Pharmaceuticals, Inc. is a pharmaceutical company focusing on high-quality, differentiated, anti-infective consumer products: Avenova^®, the premier antimicrobial lid and lash spray, CelleRx^® Clinical Reset™, a breakthrough product in the beauty category, and NeutroPhase^® Skin and Wound Cleanser for wound healing.

About DERMAdoctor:

DERMAdoctor delivers on the promise that clinical skin therapy can be fun and easy, while still delivering significant, measurable results. According to its founder, Dr. Audrey Kunin, “We are a clinical skincare brand from a female dermatologist's point of view. Designed to be elegant, hypoallergenic, multitasking, problem-solving and highly effective.” Additional information is available at www.dermadoctor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005321/en/

Socialize and Stay informed on NovaBay’s progress

Like us on Facebook

Follow us on Twitter

Connect with NovaBay on LinkedIn

Visit NovaBay’s Website

Avenova Purchasing Information

For NovaBay Avenova purchasing information:

Please call 800-890-0329 or email sales@avenova.com.

Avenova.com

CelleRx Clinical Reset Purchasing Information

For NovaBay CelleRx Clinical Reset purchasing information

Please call 877-CELLERX

www.CelleRx.com

NovaBay Contact

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investor Contact

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay Pharmaceuticals, Inc.

FAQ

What is the purpose of NovaBay's acquisition of DERMAdoctor?

The acquisition aims to enhance NovaBay's product portfolio in clinical skincare.

When is the NovaBay Pharmaceuticals conference call about DERMAdoctor?

The conference call is scheduled for September 29, 2021, at 4:30 p.m. ET.

How can I access the webcast for the NovaBay Pharmaceuticals conference call?

The webcast will be available on NovaBay's investor events page.

Will there be a replay of the NovaBay conference call?

Yes, a replay of the call will be available until October 14, 2021.

What financial impact is expected from the acquisition of DERMAdoctor?

The acquisition is expected to expand market presence and drive potential revenue growth for NovaBay.